AFCG AFC Gamma Inc
565
$12.49
$0.26
(2.13%)
| Watchers | 565 |
| 52-Wk Low | $10.41 |
| 52-Wk High | $14.60 |
| Market Cap | $252.76M |
| Volume | 55,163.00 |
| 52-Wk High | $14.60 |
| 52-Wk Low | $10.41 |
AFC Gamma (AFCG) Shares Cross Below 200 DMADividend Channel • about 2 months ago
In trading on Monday, shares of AFC Gamma Inc (AFCG) crossed below their 200 day moving average of 12.18, changing hands as low as 11.93 per share. AFC Gamma Inc shares are currently...
Share to Feed
In trading on Monday, shares of AFC Gamma Inc (AFCG) were yielding above the 16% mark based on its quarterly dividend (annualized to 1.92), with the stock changing hands as low as 11.93 on...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Represents AFC Gamma's Second Transaction in Florida's Growing Medical Cannabis MarketWEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AFC Gamma, Inc. (NASDAQ:AFCG) ( AFC Gamma or the...
AFC Gamma, Inc. (NASDAQ:AFCG Get Free Report) announced a quarterly dividend on Monday, March 4th, Zacks reports. Investors of record on Sunday, March 31st will be given a dividend of 0.48...
On 3/27/24, AFC Gamma Inc (AFCG) will trade ex-dividend, for its quarterly dividend of 0.48, payable on 4/15/24. As a percentage of AFCGs recent stock price of 13.03, this dividend...
AFC Gamma, Inc. (NASDAQ:AFCG Get Free Report) saw a large growth in short interest during the month of February. As of February 29th, there was short interest totalling 648,300 shares, a...
Gadsden Properties (OTCMKTS:GADS Get Free Report) and AFC Gamma (NASDAQ:AFCG Get Free Report) are both small-cap finance companies, but which is the better business? We will compare...
AFC Gamma (NASDAQ:AFCG Get Free Report) released its earnings results on Thursday. The company reported $0.50 EPS for the quarter, topping analysts consensus estimates of $0.49 by...
Key Takeaways; Cannabis Sector
Curaleaf reported strong growth in 2023, amidst global expansion plans.
MariMed reported revenue growth and net loss in 2023; alongside 2024 growth...